PetMed Express Inc (NASDAQ:PETS) — Stock Price
PetMed Express Inc (NASDAQ:PETS) is currently trading at $1.97 USD, down 0.51% today. Over the past 52 weeks, shares have ranged between $1.60 and $3.90. This page tracks PetMed Express Inc's live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see PetMed Express Inc market cap and net worth.
PetMed Express Inc (PETS) Stock Price Chart — Daily History & Trading Volume
The chart below tracks PetMed Express Inc's daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
PetMed Express Inc Income Statement — Revenue, Profit & Earnings by Year
PetMed Express Inc's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2026 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $226.97 Million | $274.10 Million | $256.58 Million | $273.42 Million | $303.58 Million |
| Cost of Revenue | $157.84 Million | $196.38 Million | $185.84 Million | $198.08 Million | $219.27 Million |
| Gross Profit | $69.14 Million | $77.71 Million | $71.01 Million | $75.34 Million | $84.32 Million |
| Research & Development | — | — | — | — | — |
| SG&A | $38.65 Million | $55.25 Million | $49.47 Million | $30.83 Million | $28.29 Million |
| Total Operating Expenses | $70.67 Million | $84.67 Million | $64.68 Million | $49.63 Million | $53.78 Million |
| Operating Income | $-1.53 Million | $-6.96 Million | $6.55 Million | $25.71 Million | $30.53 Million |
| EBITDA | $6.71 Million | $783.00K | $10.99 Million | $29.81 Million | $32.96 Million |
| EBIT | $-330.00K | $-6.27 Million | $7.45 Million | $27.07 Million | $30.53 Million |
| Interest Expense | — | $3.01 Million | $3.01 Million | $335.00K | $1.21 Million |
| Income Before Tax | $-587.00K | $-6.27 Million | $7.45 Million | $27.07 Million | $30.95 Million |
| Income Tax Expense | $5.68 Million | $1.19 Million | $2.31 Million | $5.97 Million | $7.03 Million |
| Net Income | $-6.27 Million | $-7.46 Million | $5.14 Million | $21.10 Million | $23.92 Million |
PetMed Express Inc Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes PetMed Express Inc's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2026 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | $148.70 Million | $169.88 Million | $170.00 Million | $176.32 Million | $187.50 Million |
| Total Current Assets | $78.87 Million | $93.65 Million | $130.43 Million | $151.00 Million | $161.19 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | $2.32 Million | $3.28 Million | $1.74 Million | $1.91 Million | $2.59 Million |
| Inventory | $16.20 Million | $28.56 Million | $19.02 Million | $32.45 Million | $34.42 Million |
| Property, Plant & Equipment | — | — | $26.18 Million | $24.46 Million | $25.45 Million |
| Goodwill | $26.66 Million | $26.66 Million | $0.00 | — | — |
| Total Liabilities | $63.57 Million | $73.15 Million | $60.04 Million | $34.13 Million | $46.22 Million |
| Total Current Liabilities | $62.77 Million | $72.16 Million | $57.51 Million | $33.20 Million | $44.94 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | $-53.72 Million | $-53.84 Million | $-103.09 Million | $-111.08 Million | $-118.72 Million |
| Total Stockholder Equity | $85.13 Million | $96.73 Million | $109.97 Million | $142.19 Million | $141.28 Million |
| Retained Earnings | $66.54 Million | $71.56 Million | $91.66 Million | $130.50 Million | $134.14 Million |
PetMed Express Inc Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how PetMed Express Inc generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2026 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | $4.72 Million | $4.32 Million | $27.80 Million | $18.50 Million | $40.08 Million |
| Capital Expenditures | $5.11 Million | $4.51 Million | $5.26 Million | $1.75 Million | $2.43 Million |
| Free Cash Flow | $-395.00K | $-194.00K | $22.54 Million | $16.75 Million | $37.64 Million |
| Investing Cash Flow | $-5.11 Million | $-40.67 Million | $-10.26 Million | $-1.75 Million | $-2.43 Million |
| Financing Cash Flow | $-181.00K | $-12.44 Million | $-24.54 Million | $-24.38 Million | $-22.69 Million |
| Dividends Paid | $181.00K | $12.44 Million | $24.54 Million | $24.38 Million | $22.69 Million |
| Stock-Based Compensation | $-6.59 Million | $6.87 Million | $6.62 Million | $4.55 Million | $3.31 Million |
| Depreciation | $7.04 Million | $7.06 Million | $3.55 Million | $2.74 Million | $2.43 Million |
| Change in Cash | $-576.00K | $-48.79 Million | $-6.99 Million | $-7.64 Million | $14.96 Million |
PetMed Express Inc Earnings History — EPS Actual vs. Analyst Estimates
Track PetMed Express Inc's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 11, 2026 | 0.00 | -0.13 | +100.00% |
| Feb 10, 2026 | -0.50 | -0.06 | -733.33% |
| Oct 14, 2025 | -0.56 | -0.04 | -1300.00% |
| Aug 11, 2025 | -0.06 | 0.21 | -128.57% |
| Jun 09, 2025 | -0.34 | -0.04 | -750.00% |
| Feb 10, 2025 | -0.03 | 0.01 | -400.00% |
| Nov 06, 2024 | 0.11 | -0.05 | +320.00% |
| Aug 06, 2024 | 0.18 | -0.09 | +300.00% |